Skip to content

Clinical trials

Completed Hematologic Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Completed Country / region: United Kingdom Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20091
20104
20111
20121
20133
20144
20153
20161
20173
20186
20192
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Seagen Inc.4
BioMarin Pharmaceutical3
Abbott Medical Devices2
Bayer2
Genzyme, a Sanofi Company2
Kyowa Kirin Co., Ltd.2
Swedish Orphan Biovitrum2
Takeda2
Vertex Pharmaceuticals Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases39
Blood Coagulation Disorders11
Genetic Diseases, Inborn10
Hemorrhagic Disorders9
Leukemia9
Bone Marrow Diseases8
Coagulation Protein Disorders8
Hemophilia A8
Blood Coagulation Disorders, Inherited6
Hemostatic Disorders6

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.